Are they going to keep publishing this story every six months until patients start demanding the drug, creating public pressure for insurance companies to waste

Are they going to keep publishing this story every six months until patients start demanding the drug, creating public pressure for insurance companies to waste their money on it? As far as I can tell, every news outlet has decided to publish a story about lecanemab today, and I can't detect any new information in any of them. Would love for someone more knowledgeable than me to explain if anything has changed since the result of less than a half-point difference on a checklist after 18 months. Would also love for someone knowledgeable about PR to explain how these stories are coordinated so well. Is is just a random press release getting lucky on a slow news day, or is there more coordination than that?